Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $597.5400 (-0.91%) ($590.3000 - $604.0300) on Thu. Jun. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 44 | Latest Price | $597.5400(-0.91%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(37%) IWF(36%) | Factors Impacting REGN price | REGN will decline at least -1.51% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-5%) IYT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $594.85(0.45%) | 10 Day Moving Average | $598.52(-0.16%) | 20 Day Moving Average | $591.45(1.03%) | To recent high | -3.4% | To recent low | 39.5% | Market Cap | $63.356b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |